Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Simple, fast and efficient iTOP-mediated delivery of CRISPR/Cas9 RNP in difficult-to-transduce human cells including primary T cells

13 Jul 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to CRISPR and Genetic Engineering
Share to Pluripotent Stem Cells Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 34271056
DOI: 10.1016/j.jbiotec.2021.07.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Simple, fast and efficient iTOP-mediated delivery of CRISPR/Cas9 RNP in difficult-to-transduce human cells including primary T cellsPMID 34271056Read ↗

Increasing Gene Editing Efficiency via CRISPR/Cas9- or Cas12a-Mediated Knock-In in Primary Human T CellsSemantic proximity Read ↗

High-efficiency nonviral CRISPR/Cas9-mediated gene editing of human T cells using plasmid donor DNASemantic proximity Read ↗

Exploring nano-enabled CRISPR-Cas-powered strategies for efficient diagnostics and treatment of infectious diseasesSemantic proximity Read ↗

CRISPR–Cas9 applications in T cells and adoptive T cell therapiesSemantic proximity Read ↗

Ribonucleoprotein Transfection for CRISPR/Cas9‐Mediated Gene Knockout in Primary T CellsSemantic proximity Read ↗

Current advances of CRISPR-Cas technology in cell therapySemantic proximity Read ↗

Boosting CAR-T cell therapy with CRISPR technologySemantic proximity Read ↗

Leveraging CRISPR gene editing technology to optimize the efficacy, safety and accessibility of CAR T-cell therapySemantic proximity Read ↗

Preventing large deletions and chromosome loss in engineered human primary T cells by CasPlus with optimized guide RNAsSemantic proximity Read ↗

Plasmid- or Ribonucleoprotein-Mediated CRISPR/Cas Gene Editing in Primary Murine T Cells.Semantic proximity Read ↗

Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applicationsSemantic proximity Read ↗

CRISPR/Cas9: Role of genome editing in cancer immunotherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.